The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hi sax,yes i think the next 6 month will be very interesting.we are still under the radar,its almost like a coiled spring,hopefully the true value of Bex will be reflected in the SP soon.
Thanks everyone for your input regarding the possible US IPO.I believe that Markku and the team will weigh up the next steps for the development of Bex and choose the best option to deliver the long awaited SSV.Hopefully we will see the SP start to move north soon.
Question,if faron go for an IPO in the US,where will the shares come from. As we have a small freefloat of shares,would the company issue more shares and would that mean dilution of our existing shareholding?
Thanks again sax,it does look like the Ducks are lining up for Faron in 2022.
Nice to see some chunky buys today.
Yes Koozer,the SP peaked at £4,85 on 25th of August and despite numerous positive updates has been on a steady decline.Hopefully the next update will rerate the SP back towards £5.Hopefully we will be back in SSV territory soon.
Hi Sax,thanks again for the info.Its now 2 years since the ssv.I really think Markku decided to postpone the ssv and concentrate on developing our assetts to add even more value at a later stage.I have been here since the drop from £8 and have added over the last 4 years this is now my largest holding.Like you i cant believe we are so under the radar with all the positive news we have had..Hipefully 2022 will vindicate our patience.
Goodmorning I have just read an interesting article in Saturdays Times concerning the approval of atezolizumab for people that have had surgery and chemo for lung cancer.The article mentions the Orbis programme which this drug was part of.Its an international collabaration to speed up the approval process for promising cancer treatments.I wonder if Bex is in the orbis programme,anyway it looks like immunotherapy is the way forward in treating this awful disease.
Hi CAGNEY,I understand your frustration with the downward trend of the SP,despite the recent positive updates.I didn't think we would go below £2.50 but here we are.I still have faith in Markku and the team,and hopefully the SP will start to move northward in.2022.
Thanks again sax for your synopsis of todays presentation, Markkus faith in T will hopefully be vindicated soon.
And down we go as usual.
Hi Felix,looks like a good one to me .As i read it they can do a simple blood test on patients to ascertain who will benefit most from Bex.Unfortunately a positive RNS seems to preclude a drop in the SP with Faron.Hopefully this year we will be back in ssv territory.
Thanks Troagan for posting the proactive link ,Marie Louise came across as very proffessional and positive on the use of Bex going forward..
Hi sax,thanks for your indepth analysis.
Morning Dracula,yes it is very strange that on the 1st of April two years ago the sp was over £5,since then we have had some really good updates on Bex,and T,yet the sp just seems to move between £2.50 and £5.Hopefully soon this will rerate north of £5.
Hopefully the news flow in March will have a positive effect on the SP,it was £5 not long ago.
Thanks Novice
Cheers Tilly,and thankyou for all your fact based positivity.
Thanks Pete,yes it has.
Thanks EUA,for a great birthday present!!!!!